Deltamethrin is a synthetic pyrethroid whose neurotoxicity is based on a precise mechanism: the prolongation of the opening of voltage-gated sodium channels at the level of neuronal membranes. This mode of action, shared with other pyrethroids, takes on a particular dimension with deltamethrin due to its high insecticidal potency and its massive use in mosquito control, agriculture, and domestic biocides.
Absorption Kinetics and Metabolism: How the Route of Exposure Changes Things
In its pure form, deltamethrin is a white solid that is almost insoluble in water. Its skin absorption remains limited under these conditions. Commercial formulations change the game: emulsifiable concentrates and concentrated suspensions contain co-formulants and solvents that significantly increase dermal penetration.
Hepatic metabolism degrades the molecule absorbed orally through cleavage of the ester bond, followed by oxidation. Elimination occurs via urine. The duration of exposure matters as much as the absorbed dose, a parameter that evaluations focused on the LD50 tend to overlook.
Inhalation poses the greatest occupational risk, particularly during spraying in mosquito control. Suspended droplets reach the deep respiratory pathways and bypass the skin barrier. A detailed article discusses the toxicity of deltamethrin for humans on Ma Maison Info, specifying the mechanisms of action on the body.
Neurotoxic Effects of Deltamethrin: Clinical Signs and Thresholds
The clinical picture of exposure includes facial paresthesias (tingling, skin burning), hypersalivation, and tremors. At high doses, clonic seizures may occur.
Paresthesias appear with direct contact with the skin, even below thresholds of systemic toxicity. This phenomenon, reversible within a few hours, results from a local action on sensory nerve endings and should not be confused with an allergic reaction.
Endocrine Disruption and Cumulative Exposure
The regulatory decision RD2026-18 from Health Canada, published on September 29, 2026, marks a turning point in evaluation frameworks. It takes into account aggregated exposures via oral, dermal, and respiratory routes, as well as potential cumulative effects.
Health Canada concludes that there is an acceptable risk only under approved usage conditions. In practice, the same product may be deemed safe for outdoor use around homes but problematic in a different scenario.
Operational Precautions During Insecticide Treatments
Deltamethrin presents an intrinsic danger (neurotoxicity, high aquatic toxicity). The actual risk depends on application conditions. We structure prevention around three axes.
- Personal protective equipment suited to the dominant route of exposure: FFP2 mask or half-mask with cartridge during spraying, nitrile gloves for handling concentrates, single-use coveralls for applications in confined spaces.
- Strict adherence to re-entry intervals after treatment. In school or hospital settings, returning before the prescribed time on the biocide product label exposes occupants to airborne residues.
- Storage in accordance with INRS recommendations: closed containers, away from heat, in a ventilated area. Since deltamethrin is soluble in many organic solvents, contact with incompatible plastics should be avoided.
After treatment, ventilation of the area is a priority measure to limit occupants’ exposure to airborne residues. Cleaning surfaces alone is not sufficient if the ambient air has not been renewed according to the timelines prescribed by the product label.
Environmental Impact and Aquatic Ecotoxicity of Deltamethrin
Deltamethrin is extremely toxic to aquatic organisms. Its near-insolubility in water does not make it harmless: it adsorbs onto suspended particles and sediments, where it persists. Aquatic invertebrates (daphnia, mayfly larvae) are sensitive to concentrations much lower than toxicity thresholds for mammals.
The case of Vieljeux High School in La Rochelle in 2026 illustrates the tensions related to these uses. A spraying of insecticide as part of the fight against chikungunya sparked local opposition, highlighting the conflict between public health urgency and the precautionary principle in sensitive environments.
Anses regularly evaluates biocides and plant protection products containing deltamethrin. Market authorizations now include ecotoxicity studies concerning pollinators, a critical point for agricultural uses on cereals, vineyards, and orchards.
The regulatory framework, supported by Health Canada as well as European agencies, is shifting towards a global reduction of exposure rather than mere compliance with maximum residue limits. This requires reevaluating each use on a case-by-case basis depending on the local context and exposed populations.
For professionals, this evolution implies documenting each intervention and justifying the choice of deltamethrin over non-chemical alternatives or available substitute molecules.
